Vascular	O
endothelial	O
growth	O
factor	O
-	O
B	O
and	O
vascular	O
endothelial	O
growth	O
factor	O
-	O
C	O
expression	O
in	O
renal	B-Cancer
cell	I-Cancer
carcinomas	I-Cancer
:	O
regulation	O
by	O
the	O
von	O
Hippel	O
-	O
Lindau	O
gene	O
and	O
hypoxia	O
.	O

Angiogenesis	O
is	O
essential	O
for	O
tumor	B-Cancer
growth	O
and	O
metastasis	O
.	O

It	O
is	O
regulated	O
by	O
numerous	O
angiogenic	O
factors	O
,	O
one	O
of	O
the	O
most	O
important	O
being	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
.	O

Recently	O
VEGF	O
-	O
B	O
and	O
VEGF	O
-	O
C	O
,	O
two	O
new	O
VEGF	O
family	O
members	O
,	O
have	O
been	O
identified	O
that	O
bind	O
to	O
the	O
tyrosine	O
kinase	O
receptors	O
flt	O
-	O
1	O
(	O
VEGFR1	O
)	O
,	O
KDR	O
(	O
VEGFR2	O
)	O
,	O
and	O
flt	O
-	O
4	O
(	O
VEGFR3	O
)	O
.	O

Although	O
the	O
importance	O
of	O
VEGF	O
-	O
A	O
has	O
been	O
shown	O
in	O
renal	B-Cancer
carcinomas	I-Cancer
,	O
the	O
contribution	O
of	O
these	O
new	O
ligands	O
in	O
kidney	B-Cancer
tumors	I-Cancer
is	O
not	O
clear	O
.	O

We	O
have	O
,	O
therefore	O
,	O
measured	O
the	O
mRNA	O
level	O
of	O
VEGF	O
-	O
B	O
and	O
VEGF	O
-	O
C	O
together	O
with	O
their	O
receptors	O
by	O
RNase	O
protection	O
assay	O
(	O
RPA	O
)	O
in	O
26	O
normal	O
kidney	B-Multi-tissue_structure
samples	I-Multi-tissue_structure
and	O
45	O
renal	B-Cancer
cell	I-Cancer
cancers	I-Cancer
.	O

We	O
observed	O
a	O
significant	O
up	O
-	O
regulation	O
of	O
VEGF	O
-	O
B	O
(	O
P	O
=	O
0	O
.	O
002	O
)	O
but	O
not	O
VEGF	O
-	O
C	O
(	O
P	O
=	O
0	O
.	O
3	O
)	O
in	O
neoplastic	B-Organ
kidney	I-Organ
compared	O
with	O
normal	O
tissues	B-Tissue
.	O

In	O
addition	O
,	O
although	O
VEGF	O
receptors	O
were	O
higher	O
in	O
tumors	B-Cancer
than	O
normal	O
kidney	B-Organ
,	O
there	O
was	O
a	O
significant	O
up	O
-	O
regulation	O
of	O
only	O
flt	O
-	O
1	O
(	O
P	O
=	O
0	O
.	O
003	O
)	O
but	O
not	O
KDR	O
(	O
P	O
=	O
0	O
.	O
12	O
)	O
or	O
flt	O
-	O
4	O
(	O
P	O
=	O
0	O
.	O
09	O
)	O
.	O

There	O
was	O
also	O
a	O
significant	O
correlation	O
between	O
VEGF	O
-	O
C	O
and	O
both	O
of	O
its	O
receptors	O
flt	O
-	O
4	O
(	O
P	O
=	O
0	O
.	O
006	O
)	O
and	O
KDR	O
(	O
P	O
=	O
0	O
.	O
03	O
)	O
but	O
no	O
association	O
between	O
VEGF	O
-	O
B	O
and	O
its	O
receptor	O
flt	O
-	O
1	O
(	O
P	O
=	O
0	O
.	O
23	O
)	O
.	O

A	O
significant	O
increase	O
was	O
observed	O
in	O
flt	O
-	O
1	O
(	O
P	O
less	O
than	O
0	O
.	O
001	O
)	O
,	O
KDR	O
(	O
P	O
=	O
0	O
.	O
02	O
)	O
,	O
and	O
flt	O
-	O
4	O
(	O
P	O
=	O
0	O
.	O
01	O
)	O
but	O
not	O
VEGF	O
-	O
B	O
(	O
P	O
=	O
0	O
.	O
82	O
)	O
or	O
VEGF	O
-	O
C	O
(	O
P	O
=	O
0	O
.	O
52	O
)	O
expression	O
in	O
clear	B-Cell
cell	I-Cell
compared	O
with	O
chromophil	B-Cancer
(	I-Cancer
papillary	I-Cancer
)	I-Cancer
carcinomas	I-Cancer
.	O

No	O
significant	O
association	O
was	O
demonstrated	O
between	O
VEGF	O
-	O
B	O
,	O
VEGF	O
-	O
C	O
,	O
flt	O
-	O
1	O
,	O
KDR	O
,	O
and	O
flt	O
-	O
4	O
with	O
patient	O
sex	O
,	O
patient	O
age	O
,	O
or	O
tumor	B-Cancer
size	O
(	O
P	O
greater	O
than	O
0	O
.	O
05	O
)	O
.	O

The	O
effect	O
of	O
von	O
Hippel	O
-	O
Lindau	O
(	O
VHL	O
)	O
gene	O
and	O
hypoxia	O
on	O
VEGF	O
-	O
B	O
and	O
VEGF	O
-	O
C	O
expression	O
in	O
the	O
renal	B-Cell
carcinoma	I-Cell
cell	I-Cell
line	I-Cell
786	I-Cell
-	I-Cell
0	I-Cell
transfected	O
with	O
wild	O
-	O
type	O
and	O
mutant	O
VHL	O
was	O
determined	O
by	O
growing	O
cells	B-Cell
under	O
21	O
%	O
O2	O
-	O
and	O
0	O
.	O
1	O
%	O
O2	O
.	O

In	O
wild	B-Cell
-	I-Cell
type	I-Cell
VHL	I-Cell
cells	I-Cell
,	O
whereas	O
VEGF	O
-	O
A	O
was	O
significantly	O
up	O
-	O
regulated	O
under	O
hypoxic	O
compared	O
with	O
normoxic	O
conditions	O
(	O
P	O
less	O
than	O
0	O
.	O
001	O
)	O
,	O
expression	O
of	O
VEGF	O
-	O
C	O
was	O
reduced	O
(	O
P	O
less	O
than	O
0	O
.	O
002	O
)	O
.	O

Nevertheless	O
,	O
the	O
repression	O
of	O
VEGF	O
-	O
C	O
was	O
lost	O
in	O
mutant	B-Cell
VHL	I-Cell
cell	I-Cell
lines	I-Cell
under	O
hypoxia	O
.	O

In	O
contrast	O
VEGF	O
-	O
B	O
was	O
not	O
regulated	O
by	O
VHL	O
despite	O
clear	O
up	O
-	O
regulation	O
in	O
vivo	O
.	O

These	O
findings	O
strongly	O
support	O
an	O
enhanced	O
role	O
for	O
this	O
pathway	O
in	O
clear	B-Cancer
cell	I-Cancer
carcinomas	I-Cancer
by	O
regulating	O
angiogenesis	O
and	O
/	O
or	O
lymphangiogenesis	O
.	O

The	O
study	O
shows	O
that	O
clear	B-Cancer
cell	I-Cancer
tumors	I-Cancer
are	O
able	O
to	O
up	O
-	O
regulate	O
angiogenic	O
growth	O
factor	O
receptors	O
more	O
efficiently	O
than	O
chromophil	B-Cancer
(	O
papillary	B-Cancer
)	O
,	O
that	O
clear	B-Cancer
cell	I-Cancer
tumors	I-Cancer
can	O
use	O
pathways	O
independent	O
of	O
VHL	O
to	O
regulate	O
angiogenesis	O
,	O
and	O
that	O
this	O
combined	O
regulation	O
may	O
account	O
for	O
their	O
more	O
aggressive	O
phenotype	O
,	O
which	O
suggests	O
that	O
targeting	O
VEGFR1	O
(	O
flt	O
-	O
l	O
)	O
may	O
be	O
particularly	O
effective	O
in	O
these	O
tumor	B-Cancer
types	O
.	O

